Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Ignatavicius: Medical-Surgical Nursing, 7th Edition Chapter 45: Care of Patients with Problems of the Central Nervous System: The Spinal Cord Key Points - Print Spinal cord problems share a common characteristic of impaired mobility. The patient’s ability to perform activities of daily living is often affected. Sensory function may also be impaired, either temporarily or permanently. Assess for the need for adaptive/assistive devices to become independent in ADLs. Implement bowel and bladder retraining programs for patients with spinal diseases. Refer patients to appropriate resources, such as a specialists for urological problems Recognize progressive neurologic diseases, such as MS, require the patient to adjust to major life changes. Encourage patients to share their feelings about life-altering neurodegenerative disease. MULTIPLE SCLEROSIS Multiple sclerosis (MS) is a chronic autoimmune disease that affects the myelin sheath and conduction pathway of the central nervous system and is a leading cause of neurologic disability in young adults. This chronic disease is characterized by periods of remission and exacerbation of an inflammatory response that results in demyelinization, but may become progressive without remission The four major types of MS include: o Relapsing-remitting o Primary progressive o Secondary progressive o Progressive-relapsing Since there is genetic predisposition, having a first-degree relative such as a parent or sibling with MS increases a person’s risk of developing the disease. EMG may help make a differential diagnosis to rule out multiple sclerosis or amyotrophic lateral sclerosis. Magnetic resonance imaging demonstrates the presence of plaques and is considered diagnostic for MS. Current therapies for MS treat a dysfunctional immune system, using a variety of medications to control the disease, decrease symptoms, and slow progression. o Fingolimod (Gilenya) is the first oral immunomodulator approved for the management of MS. o Refer to pre-lecture work meds To maintain maximum strength, function, and independence, continuity of care with an interdisciplinary team in both the rehabilitation and home setting is necessary. Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.